Promega Corporation

Luminogenic Enzyme Substrates: The Basis for a New Paradigm in Assay Design

Share

  • Share
  • Print
  • Email
  • Download PDF

Abstract

Luciferin derivatives as luminogenic substrates provide the basis for a new paradigm in enzyme assay design that brings the advantages of bioluminescence—superior sensitivity, resistance to interference, and ease of use—to the enzymology researcher. Here we highlight our wide selection of bioluminescent enzyme substrates for proteases, metabolic enzymes and ß-galactosidase.

Promega Notes 100, 22–26.

Poncho L. Meisenheimer1, Martha A. O’Brien2, and James J. Cali2

1Promega Biosciences, Inc., 2Promega Corporation

Publication Date: 2008

Download Article (107 KB)

Prefer a different language?

Your country is set to Brazil. Your language is set to Português. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.